Clinical Trial Update: Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin [Phase 1]

View source ↗

Summary

Phase 1 trial in Duchenne muscular dystrophy reports improved muscle function with a combination of L-Arginine and metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• L-Arginine (L-Arginine)
• metformin (metformin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Duchenne Muscular Dystrophy | Phase 1 | Status: COMPLETED